- Home
- BCRX vs KEN Comparison
BCRX vs KEN Comparison
Compare BCRX & KEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- KEN
- Stock Information
- Founded
- BCRX 1986
- KEN 2014
- Country
- BCRX United States
- KEN Singapore
- Employees
- BCRX N/A
- KEN N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- KEN Electric Utilities: Central
- Sector
- BCRX Health Care
- KEN Utilities
- Exchange
- BCRX Nasdaq
- KEN Nasdaq
- Market Cap
- BCRX 1.6B
- KEN 1.5B
- IPO Year
- BCRX 1994
- KEN N/A
- Fundamental
- Price
- BCRX $7.49
- KEN $29.90
- Analyst Decision
- BCRX Strong Buy
- KEN
- Analyst Count
- BCRX 5
- KEN 0
- Target Price
- BCRX $15.60
- KEN N/A
- AVG Volume (30 Days)
- BCRX 1.7M
- KEN 12.6K
- Earning Date
- BCRX 11-04-2024
- KEN 12-27-2024
- Dividend Yield
- BCRX N/A
- KEN 12.75%
- EPS Growth
- BCRX N/A
- KEN N/A
- EPS
- BCRX N/A
- KEN 3.23
- Revenue
- BCRX $412,579,000.00
- KEN $742,796,000.00
- Revenue This Year
- BCRX $38.01
- KEN N/A
- Revenue Next Year
- BCRX $19.04
- KEN N/A
- P/E Ratio
- BCRX N/A
- KEN $9.29
- Revenue Growth
- BCRX 29.92
- KEN 8.29
- 52 Week Low
- BCRX $4.03
- KEN $19.63
- 52 Week High
- BCRX $8.88
- KEN $31.26
- Technical
- Relative Strength Index (RSI)
- BCRX 48.08
- KEN 52.17
- Support Level
- BCRX $7.55
- KEN $29.35
- Resistance Level
- BCRX $8.07
- KEN $30.25
- Average True Range (ATR)
- BCRX 0.33
- KEN 0.58
- MACD
- BCRX 0.00
- KEN -0.15
- Stochastic Oscillator
- BCRX 36.19
- KEN 33.66
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About KEN Kenon Holdings Ltd.
Kenon Holdings Ltd is a holding company that operates dynamic, growth-oriented, businesses. The company's operating segments include OPC; CPV Group; and ZIM. It generates maximum revenue from the OPC segment. OPC operates in the Israeli electricity generation sector, including initiating, developing, constructing, and operating power plants and selling and supplying electricity. Geographically, it derives a majority of its revenue from Israel.